BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 36197414)

  • 1. Renal amyloidosis: a new time for a complete diagnosis.
    Feitosa VA; Neves PDMM; Jorge LB; Noronha IL; Onuchic LF
    Braz J Med Biol Res; 2022; 55():e12284. PubMed ID: 36197414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal amyloidosis: an update on diagnosis and pathogenesis.
    Gupta N; Kaur H; Wajid S
    Protoplasma; 2020 Sep; 257(5):1259-1276. PubMed ID: 32447467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology and diagnosis of renal non-AL amyloidosis.
    Sethi S; Theis JD
    J Nephrol; 2018 Jun; 31(3):343-350. PubMed ID: 28828707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Al amyloidosis.
    Desport E; Bridoux F; Sirac C; Delbes S; Bender S; Fernandez B; Quellard N; Lacombe C; Goujon JM; Lavergne D; Abraham J; Touchard G; Fermand JP; Jaccard A;
    Orphanet J Rare Dis; 2012 Aug; 7():54. PubMed ID: 22909024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
    Picken MM
    Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloidosis-associated kidney disease.
    Dember LM
    J Am Soc Nephrol; 2006 Dec; 17(12):3458-71. PubMed ID: 17093068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light and heavy chain deposition disease with focal amyloid deposition diagnosed with mass spectrometry: a case report.
    Shimamoto Y; Takahashi N; Katoh N; Matsui Y; Mochizuki Y; Ito M; Yazaki M; Kametani F; Kasuno K; Sekijima Y; Naiki H; Iwano M
    BMC Nephrol; 2023 Jun; 24(1):187. PubMed ID: 37365566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current trends in diagnosis and management of cardiac amyloidosis.
    Esplin BL; Gertz MA
    Curr Probl Cardiol; 2013 Feb; 38(2):53-96. PubMed ID: 23337445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2024 Feb; 99(2):309-324. PubMed ID: 38095141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects of systemic amyloid diseases.
    Obici L; Perfetti V; Palladini G; Moratti R; Merlini G
    Biochim Biophys Acta; 2005 Nov; 1753(1):11-22. PubMed ID: 16198646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis.
    Sethi S; Dasari S; Amin MS; Vrana JA; Theis JD; Alexander MP; Kurtin PJ
    Kidney Int; 2017 Apr; 91(4):964-971. PubMed ID: 28139293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into systemic amyloidosis: the importance of diagnosis of specific type.
    Picken MM
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):196-203. PubMed ID: 17420662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2022 Jun; 97(6):818-829. PubMed ID: 35429180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing.
    Leung N; Nasr SH; Sethi S
    Blood; 2012 Oct; 120(16):3206-13. PubMed ID: 22948045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis.
    Sethi S; Theis JD; Leung N; Dispenzieri A; Nasr SH; Fidler ME; Cornell LD; Gamez JD; Vrana JA; Dogan A
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2180-7. PubMed ID: 20876678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines.
    Sipe JD; Benson MD; Buxbaum JN; Ikeda SI; Merlini G; Saraiva MJ; Westermark P
    Amyloid; 2016 Dec; 23(4):209-213. PubMed ID: 27884064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Amyloidosis.
    Mohamed N; Nasr SH
    Surg Pathol Clin; 2014 Sep; 7(3):409-25. PubMed ID: 26837447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological evaluation of the distribution of systemic AA-amyloidosis in nine domestic shorthair cats.
    Moccia V; Vogt AC; Ricagno S; Callegari C; Vogel M; Zini E; Ferro S
    PLoS One; 2023; 18(11):e0293892. PubMed ID: 37917747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics.
    Li Y; Zhang Y; Zhou X; Xue X; Wang M; Kang D; Zhou Y; Hu R; Quan S; Xing G; Yang J
    BMC Nephrol; 2023 Mar; 24(1):50. PubMed ID: 36894904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.